Luke P. Akard
- Hematology top 1%
- Genetics top 2%
- Oncology top 10%
- Molecular Biology
- Rheumatology top 5%
- Co-authors
- Michael J. DuganJan JansenJames ThompsonJohn EdwardsJörge E. CortesVictoria KennedyGertrude A. HusterBetsy L. Fife
- Topics
- Chronic Lymphocytic Leukemia Research (33 papers)Chronic Myeloid Leukemia Treatments (33 papers)Hematopoietic Stem Cell Transplantation (14 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Luke P. Akard
77 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 99
- Hematology 691
- Genetics 510
- Oncology 403
- Molecular Biology 294
- Rheumatology 225
Countries citing papers authored by Luke P. Akard
This map shows the geographic impact of Luke P. Akard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke P. Akard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke P. Akard more than expected).
Fields of papers citing papers by Luke P. Akard
This network shows the impact of papers produced by Luke P. Akard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke P. Akard. The network helps show where Luke P. Akard may publish in the future.
Co-authorship network of co-authors of Luke P. Akard
This figure shows the co-authorship network connecting the top 25 collaborators of Luke P. Akard. A scholar is included among the top collaborators of Luke P. Akard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke P. Akard. Luke P. Akard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 25 | |
| 6 | 119 | |
| 7 | 10 | |
| 8 | 27 | |
| 9 | 39 | |
| 10 | 7 | |
| 11 | 33 | |
| 12 | 22 | |
| 13 | 7 | |
| 14 | 13 | |
| 15 | 48 | |
| 16 | 13 | |
| 17 | 7 | |
| 18 | 6 | |
| 19 | 4 | |
| 20 | 15 |
About Luke P. Akard
Luke P. Akard is a scholar working on Hematology, Genetics and Oncology, having authored 78 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (33 papers), Chronic Myeloid Leukemia Treatments (33 papers) and Hematopoietic Stem Cell Transplantation (14 papers). The work is most often cited by research in Hematology (691 citations), Genetics (510 citations) and Rheumatology (225 citations). Luke P. Akard has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Michael J. Dugan, Jan Jansen, James Thompson, John Edwards, Jörge E. Cortes, Victoria Kennedy, Gertrude A. Huster, Betsy L. Fife, Kenneth Cornetta and E. Randolph Broun. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.